Evidence-based screening, clinical care and health education recommendations for Alaska Native peoples with prediabetes living in southcentral Alaska: findings from the Alaska EARTH follow-up study

• Published in: International Journal of Circumpolar Health
• Main Authors: Kathryn R. Koller, Sarah H. Nash, Julie A. Beans, Gretchen M. Day, Vanessa Y. Hiratsuka, Ai-Ling Lin, Meera Narayanan, Christi A Patten, Sherry A. Hammock, Barbara V. Howard, Jason G. Umans
• Format: Article in Journal/Newspaper
• Language: English
• Published: Taylor & Francis Group 2024
• Subjects: Urban Alaska Native; pre-diabetes; diabetes; haemoglobin A1c; fasting glucose; metabolic syndrome; Arctic medicine. Tropical medicine; RC955-962; Circumpolar Health; International Journal of Circumpolar Health; Alaska
• Online Access: https://doi.org/10.1080/22423982.2024.2343143; https://doaj.org/article/f59551bd29cc469e81d786f653bee55a

ABSTRACTPre-diabetes (pre-DM) is a strong predictor of diabetes (DM) over time. This study investigated how much of the recent increase in pre-DM identified among Alaska Native (AN) peoples living in urban southcentral Alaska may be due to changes in diagnostic methods. We used clinical and demographic data collected at baseline between 2004 and 2006 and at follow-up collected between 2015 and 2017 from the urban southcentral Alaska Education and Research Towards Health (EARTH) cohort. We used descriptive statistics and logistic regression to explore differences in demographic and clinical variables among the identified pre-DM groups. Of 388 participants in the follow-up study, 243 had A1c levels indicating pre-DM with only 20 demonstrating pre-DM also by fasting blood glucose (FBG). Current smoking was the sole predictor for pre-DM by A1c alone while abdominal obesity and elevated FBG-predicted pre-DM by A1c+FBG. No participants had an elevated FBG without an A1c elevation. A substantial portion of the rise in pre-DM found among urban southcentral AN peoples in the EARTH follow-up study was due to the addition of A1c testing. Pre-DM by A1c alone should be used to motivate behavioural changes that address modifiable risk factors, including smoking cessation, physical activity and weight management.